229 related articles for article (PubMed ID: 18183597)
1. Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer.
Howard EW; Lee DT; Chiu YT; Chua CW; Wang X; Wong YC
Int J Cancer; 2008 May; 122(9):1941-8. PubMed ID: 18183597
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of survivin is a factor responsible for differential responses of ovarian cancer cells to S-allylmercaptocysteine (SAMC).
Wu J; Zhao S; Zhang J; Qu X; Jiang S; Zhong Z; Zhang F; Wong Y; Chen H
Exp Mol Pathol; 2016 Apr; 100(2):294-302. PubMed ID: 26896649
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide.
Shirin H; Pinto JT; Kawabata Y; Soh JW; Delohery T; Moss SF; Murty V; Rivlin RS; Holt PR; Weinstein IB
Cancer Res; 2001 Jan; 61(2):725-31. PubMed ID: 11212275
[TBL] [Abstract][Full Text] [Related]
4. Combination of rapamycin and garlic-derived S-allylmercaptocysteine induces colon cancer cell apoptosis and suppresses tumor growth in xenograft nude mice through autophagy/p62/Nrf2 pathway.
Li S; Yang G; Zhu X; Cheng L; Sun Y; Zhao Z
Oncol Rep; 2017 Sep; 38(3):1637-1644. PubMed ID: 28737825
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic integration of c-myc and bcl-2 antisense molecules with docetaxel in a preclinical model of hormone-refractory prostate cancer.
Leonetti C; Biroccio A; D'Angelo C; Semple SC; Scarsella M; Zupi G
Prostate; 2007 Sep; 67(13):1475-85. PubMed ID: 17654511
[TBL] [Abstract][Full Text] [Related]
6. Garlic-derived compound S-allylmercaptocysteine (SAMC) is active against anaplastic thyroid cancer cell line 8305C (HPACC).
Liu Y; Yan J; Han X; Hu W
Technol Health Care; 2015; 23 Suppl 1():S89-93. PubMed ID: 26410334
[TBL] [Abstract][Full Text] [Related]
7. Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models.
Festuccia C; Gravina GL; D'Alessandro AM; Muzi P; Millimaggi D; Dolo V; Ricevuto E; Vicentini C; Bologna M
Endocr Relat Cancer; 2009 Jun; 16(2):401-13. PubMed ID: 19153211
[TBL] [Abstract][Full Text] [Related]
8. S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions.
Chu Q; Lee DT; Tsao SW; Wang X; Wong YC
BJU Int; 2007 Apr; 99(4):925-32. PubMed ID: 17155983
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation.
Xiao D; Pinto JT; Soh JW; Deguchi A; Gundersen GG; Palazzo AF; Yoon JT; Shirin H; Weinstein IB
Cancer Res; 2003 Oct; 63(20):6825-37. PubMed ID: 14583480
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel function of Id-1 in mediating the anticancer responses of SAMC, a water-soluble garlic derivative, in human bladder cancer cells.
Hu H; Zhang XP; Wang YL; Chua CW; Luk SU; Wong YC; Ling MT; Wang XF; Xu KX
Mol Med Rep; 2011; 4(1):9-16. PubMed ID: 21461556
[TBL] [Abstract][Full Text] [Related]
11. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
Li X; Wu JB; Chung LW; Huang WC
Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
[TBL] [Abstract][Full Text] [Related]
12. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.
Yoo J; Park SS; Lee YJ
J Cell Biochem; 2008 Aug; 104(5):1636-46. PubMed ID: 18404675
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by S-allylmercapto-L-cysteine, a biotransformed garlic derivative, on a human gastric cancer cell line.
Lee Y
Int J Mol Med; 2008 Jun; 21(6):765-70. PubMed ID: 18506370
[TBL] [Abstract][Full Text] [Related]
15. S-allylmercaptocysteine promotes MAPK inhibitor-induced apoptosis by activating the TGF-β signaling pathway in cancer cells.
Tong D; Qu H; Meng X; Jiang Y; Liu D; Ye S; Chen H; Jin Y; Fu S; Geng J
Oncol Rep; 2014 Sep; 32(3):1124-32. PubMed ID: 24970681
[TBL] [Abstract][Full Text] [Related]
16. A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression.
Chu Q; Ling MT; Feng H; Cheung HW; Tsao SW; Wang X; Wong YC
Carcinogenesis; 2006 Nov; 27(11):2180-9. PubMed ID: 16675472
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis of human gastric cancer cells line SGC 7901 induced by garlic-derived compound S-allylmercaptocysteine (SAMC).
Yan JY; Tian FM; Hu WN; Zhang JH; Cai HF; Li N
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(6):745-51. PubMed ID: 23609357
[TBL] [Abstract][Full Text] [Related]
18. The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells.
Gravina GL; Marampon F; Petini F; Biordi L; Sherris D; Jannini EA; Tombolini V; Festuccia C
Endocr Relat Cancer; 2011 Aug; 18(4):385-400. PubMed ID: 21551258
[TBL] [Abstract][Full Text] [Related]
19. S-allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions.
Liang D; Qin Y; Zhao W; Zhai X; Guo Z; Wang R; Tong L; Lin L; Chen H; Wong YC; Zhong Z
Cancer Lett; 2011 Nov; 310(1):69-76. PubMed ID: 21794975
[TBL] [Abstract][Full Text] [Related]
20. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
Hu H; Li GX; Wang L; Watts J; Combs GF; Lü J
Clin Cancer Res; 2008 Feb; 14(4):1150-8. PubMed ID: 18281549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]